澳华内镜(688212) - 2024 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2024 was ¥147,029,290.25, representing a 5.39% increase compared to ¥139,509,193.05 in the same period last year[4] - Net profit attributable to shareholders for Q3 2024 was ¥31,641,404.05, a significant increase of 345.17% from ¥7,107,658.35 in the previous year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥16,158,766.30, up 378.59% from ¥3,942,969.70 in the same period last year[4] - The company's basic earnings per share for Q3 2024 was ¥0.24, an increase of 380.00% compared to ¥0.05 in the same period last year[4] - Total operating revenue for the first three quarters of 2024 reached ¥500,553,520.06, an increase of 16.8% compared to ¥428,593,935.58 in the same period of 2023[17] - The total profit for Q3 2024 is CNY 30,088,217.24, a decrease from CNY 38,515,167.46 in Q3 2023, reflecting a decline of approximately 21.5%[19] - The net profit for Q3 2024 is CNY 36,958,353.67, down from CNY 45,489,239.23 in Q3 2023, representing a decrease of about 18.5%[19] - The net profit attributable to shareholders of the parent company is CNY 37,303,031.49, compared to CNY 45,187,021.40 in the previous year, indicating a decline of approximately 17.5%[19] - The net profit for the first three quarters of 2024 was CNY 28,139,163.17, down from CNY 38,025,753.96 in the previous year, indicating a decline of approximately 26.0%[27] Expenses and Costs - Research and development expenses totaled ¥25,771,300.30, a decrease of 29.37% from ¥36,487,271.90 in the previous year, accounting for 17.53% of operating revenue[5] - Total operating costs for the first three quarters of 2024 were ¥504,921,469.56, up from ¥424,465,174.16 in 2023, reflecting a rise of 18.9%[18] - Research and development expenses for the first three quarters of 2024 were ¥113,108,128.27, slightly up from ¥106,088,757.05 in 2023, indicating a growth of 6.3%[18] - The company's total equity increased to ¥1,397,343,158.38 from ¥1,395,158,777.46, a marginal increase of 0.2%[16] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,676,603,833.96, reflecting a 5.11% increase from the previous year[5] - Non-current assets totaled ¥729,740,584.30, compared to ¥586,862,434.46 in the previous year, marking an increase of 24.2%[16] - Current liabilities rose to ¥208,141,386.77, up from ¥141,811,852.13, reflecting a significant increase of 46.7%[16] - Non-current liabilities totaled ¥71,119,288.81, compared to ¥58,073,139.91 in the previous year, an increase of 22.4%[16] - The total liabilities increased to CNY 283,045,780.02 from CNY 168,015,854.10, representing a growth of about 68.3%[26] Cash Flow - The net cash flow from operating activities for the year-to-date was negative at -¥137,907,116.60, impacted by slower receivables and increased investments[9] - Cash inflow from operating activities for the first three quarters of 2024 is CNY 528,105,962.51, an increase from CNY 474,516,059.19 in the same period of 2023, reflecting a growth of approximately 11.3%[22] - Cash outflow from operating activities for the first three quarters of 2024 is CNY 666,013,079.11, compared to CNY 511,047,225.62 in 2023, an increase of about 30.4%[22] - The net cash flow from investing activities for Q3 2024 is CNY -11,990,148.86, an improvement from CNY -20,746,416.63 in Q3 2023[24] - The net cash flow from financing activities for Q3 2024 is CNY 50,113,987.87, compared to CNY 6,351,995.57 in Q3 2023, indicating a significant increase[24] Shareholder Information - The company reported a total of 3,811 shareholders at the end of the reporting period[10] - The largest shareholder, Gu Xiaozhou, holds 21,740,500 shares, representing 16.15% of total shares[10] - Gu Kang, the second-largest shareholder, owns 16,950,200 shares, accounting for 12.59%[10] - The company has no reported related party transactions among the top shareholders[13] Other Information - The company received significant government subsidies, contributing to the increase in net profit for the quarter[8] - The company has not indicated any new product launches or significant market expansion strategies in the current report[14] - The company did not apply new accounting standards for the first time in 2024[30]